Key result
ANGPTL3 overexpression suppresses renal cell carcinoma progression and correlates with better overall survival.
Why the study?
Angiopoietin-like 3 (ANGPTL3) exhibits abnormal expression in many cancers, but its expression pattern and functions in renal cell carcinoma (RCC) were rarely reported.
Does ANGPTL3 overexpression suppress oncogenic properties (proliferation, migration, invasion) in renal cell carcinoma cells via the Wnt/β-catenin pathway and predict survival in RCC patients?
Does ANGPTL3 overexpression suppress oncogenic properties (proliferation, migration, invasion) in renal cell carcinoma cells via the Wnt/β-catenin pathway and predict survival in RCC patients?
ANGPTL3 is downregulated in renal cell carcinoma and its overexpression suppresses tumor cell proliferation and invasion in vitro by inhibiting the Wnt/β-catenin signaling pathway, suggesting its potential as a prognostic biomarker and therapeutic target in RCC.
Answers are grounded in this paper and cite their sources.
ANGPTL3 may aid RCC prognostication; leaves open its validation as a therapeutic target.
Angiopoietin-like 3 (ANGPTL3), which is involved in new blood vessel growth, has been reported to exhibit an abnroaml expression in many different cancers. However, the expressing pattern and functions of ANGPTL3 renal cell carcinoma (RCC) were rarely reported. In this study, we observed that ANGPTL3 expression was distinctly downregulated in both RCC specimens from TCGA datasets and cell lines. Survival assays also revealed that patients with low ANGPTL3 expression exhibited a shorter overall survival and disease-free survival than those with high ANGPTL3 expression. Cell counting kit-8 (CCK-8) assay, Colony formation assay, and flow cytometry showed that overexpression of ANGPTL3 distinctly suppressed the proliferation of RCC cells, and promoted apoptosis. Transwell assays and Wound healing assays revealed that ANGPTL3 upregulation suppressed the migration and invasion of RCC cells. Then, we explored whether ANGPTL3 dysregulation influenced the alteration of Wnt/β-catenin signaling using TOP/FOP flash reporter assays and western blot. The results showed that overexpression of ANGPTL3 distinctly suppressed the activity of Wnt/β-catenin signaling. Overall, our results confirmed that overexpression of ANGPTL3 was related to the malignancy and good prognosis of RCC patients, and ANGPTL3 upregulation inhibited the tumor proliferation and metastasis via the Wnt/β-catenin pathway. ANGPTL3 may be a novel therapeutic target and a prognostic biomarker for RCC patients.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2021) studied Renal cell carcinoma (RCC) (n=515). ANGPTL3 overexpression (pcDNA3.1-ANGPTL3 vector) vs. Empty pcDNA 3.1 vector was evaluated on Overall survival (TCGA cohort) and RCC cell proliferation, apoptosis, migration, invasion, and Wnt/β-catenin signaling activity (in vitro) (p=0.0014). ANGPTL3 overexpression suppressed RCC cell proliferation, migration, and invasion via inhibiting Wnt/β-catenin signaling, and correlated with overall survival in 515 TCGA RCC patients.
Synapse has enriched 10 related papers. Consider them for comparative context: